|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
First published online 12 February 2008
doi: 10.1242/jcs.020347
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Research Article |
Cancer Research UK Institute for Cancer Studies, The University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK
* Author for correspondence (e-mail: f.berditchevski{at}bham.ac.uk)
Accepted 21 November 2007
Tumour-associated antigen L6 (L6-Ag, also known as TM4SF1) regulates tumour cell motility and invasiveness. We found that L6-Ag is abundant on the plasma membrane and on intracellular vesicles, on which it is co-localised with the markers for late endosomal/lysosomal compartments, including Lamp1/Lamp2 proteins and LBPA. Antibody internalisation and live-imaging experiments suggested that L6-Ag is targeted to late endocytic organelles (LEO) predominantly via a biosynthetic pathway. Mapping experiments showed that the presence of transmembrane regions is sufficient for directing L6-Ag to LEO. On the plasma membrane, L6-Ag is associated with tetraspanin-enriched microdomains (TERM). All three predicted cytoplasmic regions of L6-Ag are crucial for the effective recruitment of the protein to TERM. Recruitment to TERM correlated with the pro-migratory activity of L6-Ag. Depletion of L6-Ag with siRNA has a selective effect on the surface expression of tetraspanins CD63 and CD82. By contrast, the expression levels of other tetraspanins and β1 integrins was not affected. We found that L6-Ag is ubiquitylated and that ubiquitylation is essential for its function in cell migration. These data suggest that L6-Ag influences cell motility via TERM by regulating the surface presentation and endocytosis of some of their components.
Key words: L6 antigen, Tetraspan, Late endosomes, Migration, Tetraspanin
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
![]() |
S.-C. Shih, A. Zukauskas, D. Li, G. Liu, L.-H. Ang, J. A. Nagy, L. F. Brown, and H. F. Dvorak The L6 Protein TM4SF1 Is Critical for Endothelial Cell Function and Tumor Angiogenesis Cancer Res., April 15, 2009; 69(8): 3272 - 3277. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Choi, S.-A. Lee, T. K. Kwak, H. J. Kim, M. J. Lee, S.-K. Ye, S.-H. Kim, S. Kim, and J. W. Lee Cooperation between integrin {alpha}5 and tetraspan TM4SF5 regulates VEGF-mediated angiogenic activity Blood, February 19, 2009; 113(8): 1845 - 1855. [Abstract] [Full Text] [PDF] |
||||